Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Results of HIV-CORE002 trial of HIVconsv vaccines reported

Oct. 17, 2013

Hepatitis A virus cellular receptor has prognostic significance in breast cancer

Oct. 16, 2013

Preclinical studies with GLV-1h68 in sarcoma lead to phase I clinical trial

Oct. 16, 2013

Efficacy seen with PEG-rHuPH20 plus gemcitabine in pancreatic cancer

Oct. 16, 2013

Microbiotix describes activity of antibacterials with dual mechanism of action

Oct. 16, 2013

Novel FabI inhibitors active against resistant S. aureus

Oct. 16, 2013

HE-400 affects multiple pathways linked to IBS

Oct. 16, 2013

Anxiolytic activity demonstrated for RU-476

Oct. 15, 2013

CD151 antigen expression correlated with progression in advanced gastric cancer

Oct. 15, 2013

Varicella zoster vaccine candidate is immunogenic in patients with HIV infection

Oct. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...